In this study, expression of vimentin, immune checkpoint molecules (PD-1 and PD-L1), tumor-infiltrating CD8+ T cells, and regulatory T cells (Tregs) were assessed by immunohistochemical staining to reflect immune status in RCC. The gene discussed is VIM; the disease is renal cell carcinoma.